Search | SocialyTime

added blog Other

2025-10-16 06:22:41 -

Minimal Residual Disease Market Growth Accelerates with Advanced Molecular Diagnostics and Personalized Oncology Solutions

The global Minimal Residual Disease Market was valued at USD 2.53 billion in 2024 and is expected to reach USD 9.16 billion by 2034, growing at a CAGR of 13.7%. Increasing prevalence of hematologic cancers, rising demand for precision oncology, and the integration of advanced molecular diagnostic techniques are fueling market growth. Minimal residual...

0 Comments 0 Shares 790 Views 0 Reviews